The Pharmaceutical Research and Manufacturers of America has waded into the mifepristone controversy by filing an amicus brief – along with other industry stakeholders – asking for a reversal of a lower court decision in Alliance for Hippocratic Medicine v. the U.S. Food and Drug Administration. More than 250 congressional Democrats have also filed a brief urging an appeals
Today's Supreme Court ruling striking down Roe v. Wade has implications for health insurance coverage, according to healthinsurance.org. The 6-3 ruling that unwinds close to 50 years of a woman's right to an abortion now leaves that decision to individual states. An estimated half of them already have abortion restrictions in place or are expected to implement restrictions.
The Supreme Court on Wednesday handed up a ruling in favor of hospitals' claims to 340B drug reimbursement, but left questions for providers as to how they will be made whole for the two years they didn't receive billions from the Department of Health and Human Services, or what comes next.